Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA
- PMID: 29372485
- PMCID: PMC5955811
- DOI: 10.1007/s11764-017-0669-1
Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA
Abstract
Background: Consumer credit may reflect financial hardship that patients face due to cancer treatment, which in turn may impact ability to manage health after cancer; however, credit's relationship to economic burden and health after cancer has not been evaluated.
Methods: From May to September 2015, 123 women with a history of breast cancer residing in Pennsylvania or New Jersey completed a cross-sectional survey of demographics, socioeconomic position, comorbidities, SF-12 self-rated health, economic burden since cancer diagnosis, psychosocial stress, and self-reported (poor to excellent) credit quality. Ordinal logistic regression evaluated credit's contribution to economic burden and self-rated health.
Results: Mean respondent age was 64 years. Mean year from diagnosis was 11.5. Forty percent of respondents were Black or Other and 60% were White. Twenty-four percent self-reported poor credit, and 76% reported good to excellent credit quality. In adjusted models, changing income, using savings, borrowing money, and being unable to purchase a health need since cancer were associated with poorer credit. Better credit was associated with 7.72 ([1.22, 14.20], p = 0.02) higher physical health t-score, and a - 2.00 ([- 3.92, - 0.09], p = 0.04) point change in psychosocial stress.
Conclusions: This exploratory analysis establishes the premise for consumer credit as a marker of economic burden and health for breast cancer survivors. Future work should validate these findings in larger samples and for other health conditions.
Implications for cancer survivors: Stabilizing and monitoring consumer credit may be a potential intervention point for mitigating economic burden after breast cancer.
Keywords: Breast cancer; Credit; Economic burden; Lymphedema; Socioeconomic position; Survivorship; USA.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflicts of interest.
References
Publication types
MeSH terms
Grants and funding
- P30CA006973/CA/NCI NIH HHS/United States
- R25MH083620/MH/NIMH NIH HHS/United States
- P30AI094189/National Institute of Allergy and Infectious Diseases/International
- K01CA184288/CA/NCI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- R01CA106851/CA/NCI NIH HHS/United States
- P30 AI094189/AI/NIAID NIH HHS/United States
- R25 MH083620/MH/NIMH NIH HHS/United States
- K01AG04176/AG/NIA NIH HHS/United States
- P30 CA006973/CA/NCI NIH HHS/United States
- R01 CA106851/CA/NCI NIH HHS/United States
- K01 CA184288/CA/NCI NIH HHS/United States
- P30 AI045008/AI/NIAID NIH HHS/United States
- U54 CA155850/CA/NCI NIH HHS/United States
- 1UL1TR001079/National Center for Advancing Translational Sciences (US)/International
- K01 AG041763/AG/NIA NIH HHS/United States
- 1U54CA155850/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical